Scott Kindle, MD
Dermatology · Yankton, SDNPI 1144587353
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $281 of the $451 with a category attached, or 62.3%. Johnson & Johnson accounts for 64.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $235 and has fallen 50.8% since, to $115 in 2025. That places this record below the midpoint for dermatology clinicians in SD, where the typical reported total is $1,250.
Across 26 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$293
- Novartis$45
- Regeneron Healthcare Solutions, Inc.$41
- Sanofi$32
- Pfizer$15
- Kyowa Kirin, Inc.$14
- plus $11 from 1 others
What the payments were for
- Food & beverage$28162%
- Education$17038%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $293 |
| Novartis | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Sanofi | 2 | $32 |
| Pfizer | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Amgen | 1 | $11 |
How this compares
$451 in reported general payments places this provider in the 30th percentile of 44 dermatology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $132,025 |
| Taltz AutoinjectorIxekizumab | 13 | $79,511 |
| Dupixent PenDupilumab | 20 | $77,186 |
| Dupixent SyringeDupilumab | 18 | $71,881 |
| Fluorouracil | 199 | $17,164 |
| Clobetasol Propionate | 114 | $7,036 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 67 | $3,088 |
| Mycophenolate Mofetil | 42 | $2,499 |
| Tacrolimus | 22 | $2,419 |
| Metronidazole | 50 | $1,923 |
| Calcipotriene | 18 | $1,854 |
| Clindamycin Phosphate | 39 | $1,587 |
| Ketoconazole | 76 | $1,562 |
| Triamcinolone Acetonide | 151 | $1,300 |
| Doxycycline Hyclate | 42 | $1,260 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Yankton
- James YoungYankton$267
- Jana JohnsonSioux Falls$2.1M
- Ty HansonAberdeen$982K
- Lycia ThornburgRapid City$100K
- Carmen SchwartzSioux Falls$10K
- Michelle DafferDakota Dunes$8K
- Sarah SarbackerSioux Falls$8K
- Tamara PolingRapid City$7K
- Kendra WatsonSioux Falls$6K
- Maren GaulRapid City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.